+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vaiomer SAS - Product Pipeline Analysis, 2018 Update

  • PDF Icon

    Company Profile

  • 20 Pages
  • May 2018
  • GlobalData
  • ID: 4539789
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Vaiomer SAS (Vaiomer) is a biotechnology company and contract research organization (CRO) with focus on the research, discovery, development and commercialization of innovative tools, novel biomarkers and therapeutic drugs for the treatment of cardiometabolic diseases. The company offers research services in tissue microbiota, target development, biomakers development and active ingredient validation. Vaiomer utilizes 16S metagenomics, computational biology and transcriptomic technologies identifies bacterial community profiles and target-genes, which act as key regulators of metabolic disease cascade. It also provides microbial translocation assessment services and tools for blood bacterial DNA quantification plasma LPS measurement, bacterial translocation markers development and tissue bacteria targeted metagenomic sequencing.The company develops early prognosis and therapies of numerous diseases such as obesity, diabetes, NASH, NAFLD, liver fibrosis, cirrhosis, cardiac failure, alzheimer, parkinson, AIDS, septicemia, etc. Vaiomer is headquartered in Labege, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

  • The report analyzes all pipeline products in development for the company Vaiomer SAS

  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

  • The report provides detailed description of products in development, technical specification and functions

  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

  • To formulate effective Research & Development strategies

  • Develop market-entry and market expansion strategies

  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

  • Vaiomer SAS Company Overview

  • Vaiomer SAS Company Snapshot

  • Vaiomer SAS Pipeline Products and Ongoing Clinical Trials Overview

  • Vaiomer SAS - Pipeline Analysis Overview

  • Vaiomer SAS - Key Facts

  • Vaiomer SAS - Major Products and Services

  • Vaiomer SAS Pipeline Products by Development Stage

  • Vaiomer SAS Pipeline Products Overview

  • eu-bac Blood Test

  • eu-bac Blood Test Product Overview

  • lpxB-gen Assay

  • lpxB-gen Assay Product Overview

  • nu-bac Test

  • nu-bac Test Product Overview

  • p-bac Test

  • p-bac Test Product Overview

  • r-bac Test

  • r-bac Test Product Overview

  • Vaiomer SAS - Key Competitors

  • Vaiomer SAS - Key Employees

  • Vaiomer SAS - Locations And Subsidiaries

  • Head Office

  • Appendix

  • Methodology

  • About

  • Contact

  • Disclaimer

List of Tables
  • Vaiomer SAS Pipeline Products and Ongoing Clinical Trials Overview

  • Vaiomer SAS Pipeline Products by Equipment Type

  • Vaiomer SAS Pipeline Products by Indication

  • Vaiomer SAS, Key Facts

  • Vaiomer SAS, Major Products and Services

  • Vaiomer SAS Number of Pipeline Products by Development Stage

  • Vaiomer SAS Pipeline Products Summary by Development Stage

  • eu-bac Blood Test - Product Status

  • eu-bac Blood Test - Product Description

  • lpxB-gen Assay - Product Status

  • lpxB-gen Assay - Product Description

  • nu-bac Test - Product Status

  • nu-bac Test - Product Description

  • p-bac Test - Product Status

  • p-bac Test - Product Description

  • r-bac Test - Product Status

  • r-bac Test - Product Description

  • Vaiomer SAS, Key Employees

  • Glossary

List of Figures
  • Vaiomer SAS Pipeline Products by Equipment Type

  • Vaiomer SAS Pipeline Products by Development Stage

Companies Mentioned

A selection of companies mentioned in this report includes:

  • XenTech SAS
  • Hybrigenics Services SAS
  • Firalis SAS